- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00678496
Cognitive Behavioural Therapy Software for the Treatment of Depression in People With Multiple Sclerosis (CoSMoS)
Computerised Cognitive Behavioural Therapy for Treatment of Depression in MS (CoSMoS): Clinical Trial Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
South Yorkshire
-
Sheffield, South Yorkshire, United Kingdom, S10 3TG
- Sheffield Teaching Hospitals NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged 18+
- Diagnosis of MS confirmed by neurologist
- Beck Depression Inventory-II score of at least 14 on two consecutive occasions
- Not currently or within past three months receiving any treatment from a psychologist, psychotherapist or psychiatrist.
- Willingness to be randomised to CCBT, at home or primary care facility or treatment as usual.
Exclusion Criteria:
- Unable to read or write English
- Beck Depression Inventory score of at least 29 on two consecutive occasions
- Active suicidal ideas
Current or life-time diagnosis of any of the following:
- psychosis
- organic mental disorder;
- alcohol or drug dependency
- Kurtzke Expanded Disability Status Scale (EDSS) score of 8.5 or above
- Unable to use the CCBT package due to physical disability
- Unable to use the CCBT package due to cognitive symptoms (mini-mental state of 20 below or if, in the opinion of the study psychologist, the individual would be unlikely to benefit from CCBT)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1
CBT software delivered at home or in a primary care facility (n=12)
|
Beating the Blues is a CBT-based software package for patients with anxiety and/or depression.
The CBT strategies used include: identifying thinking errors, challenging automatic negative thoughts, modifying attributional style and identifying core beliefs.
The behavioural techniques used include graded exposure, sleep management, problem solving, task breakdown and activity scheduling.
The programme consists of a 15 minute "Introduction to Therapy" video plus eight computer-interactive sessions of approximately 50 minutes each in duration.
Each session consists of a mix of cognitive and behavioural strategies, which are customised to the patient's individual problems.
The eight computer sessions are designed to be taken weekly, or thereabouts, and each session builds on the previous one.
Other Names:
|
Other: 2
Treatment as usual (n=12)
|
Participants in the usual care arm are asked to refrain from accessing psychological services during their participation in the study, but may be prescribed anti-depressants or referred to a counsellor by their general practitioner.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Self-reported Symptoms of Depression, as Measured by Total BDI-II Score
Time Frame: 21 weeks
|
Beck Depression Inventory II-21 Item (BDI-II) - a self-report measure of severity of symptoms of depression. This is scored by summing the ratings for the 21 items. Each item is rated on a 4-point scale ranging from 0 to 3. The maximum total score is 63 (severe depression). The study reports change from baseline at 21 weeks. |
21 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Disease-specific Quality of Life, Measured on the Multiple Sclerosis Impact Scale-29 Item (MSIS-29)
Time Frame: Eight weeks or on completion of CCBT (whichever is later), and three months thereafter.
|
The Multiple Sclerosis Impact Scale (MSIS-29) is a 29-item self-report measure with 20 items associated with a physical scale and 9 items with a psychological scale. Items ask about the impact of MS on day-to-day life in the past two weeks. All items have 5 response options: 1 "not at all" to 5"extremely". Each of the two scales are scored by summing the responses across items, then converting to a 0-100 scale where 100 indicates greater impact of disease on daily function (worse health). This study measured the change from baseline at 8 weeks and 21 weeks. |
Eight weeks or on completion of CCBT (whichever is later), and three months thereafter.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Cindy L Cooper, PhD, University of Sheffield
- Study Chair: Glenys D Parry, PhD, University of Sheffield
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Pathologic Processes
- Nervous System Diseases
- Mood Disorders
- Immune System Diseases
- Demyelinating Autoimmune Diseases, CNS
- Autoimmune Diseases of the Nervous System
- Demyelinating Diseases
- Autoimmune Diseases
- Depression
- Depressive Disorder
- Multiple Sclerosis
- Sclerosis
Other Study ID Numbers
- 112276
- EudraCT number: 2008-001039-37
- MS Society: 845/06
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
Clinical Trials on CBT Software
-
Peking University Sixth HospitalPeking University First Hospital; Sichuan Provincial People's Hospital; Shenzhen... and other collaboratorsRecruiting
-
Hams Hamed AbdelrahmanCompletedAccuracy of Digital Dental ModelEgypt
-
University of California, San FranciscoRecruitingMild Cognitive Impairment | Long-Term Memory DeclineUnited States
-
The Methodist Hospital Research InstituteNational Institute on Aging (NIA)CompletedVirtual RealityUnited States
-
Cairo UniversityRecruitingSegmentation; BoneEgypt
-
Wuhan Union Hospital, ChinaCompleted
-
Methinks Software SLNot yet recruitingBrain Ischemia | Stroke, Ischemic | Stroke, Acute | Stroke Hemorrhagic
-
Madigan Army Medical CenterTelemedicine & Advanced Technology Research Center; Analytics4Medicine, Inc.Unknown
-
ProlaioRecruitingHeart Failure | Cardiomyopathy, Hypertrophic | Left Ventricular HypertrophyUnited States
-
Medical Decision Logic, Inc.Unknown